Skip to main
STAA

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 14%
Buy 0%
Hold 86%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical Co is well-positioned for growth, benefiting from the projected expansion of the ophthalmic surgical and diagnostic devices market, which is expected to reach $20.1 billion by 2025 at a compound annual growth rate of 2.9%. The company's implantable Collamer lenses (ICLs) are experiencing significant growth in market share, increasing from 14.3% in 2019 to a projected 26.5% in 2025, driven by their advantages over traditional corneal laser procedures. Additionally, the recent amended merger agreement with Alcon, raising the acquisition price to $30.75, reflects confidence in Staar's recovery and growth trajectory, enhancing its competitive positioning within the industry.

Bears say

Staar Surgical Co. is facing significant challenges characterized by declining revenue, notably an unprecedented 99% year-over-year drop in Chinese sales during the first quarter of 2025, which has severely impacted the company's overall financial performance. Despite some recovery in subsequent quarters, the company continues to exhibit EBITDA losses and cash consumption, coupled with strategic uncertainty, stalling any prospects for the sustained growth necessary for a premium valuation. Furthermore, the combination of market skepticism regarding the turnaround narrative and increasing competition in China poses substantial risk, suggesting that Staar Surgical's stock may remain under pressure as investors reassess the company's growth potential and execution capabilities.

STAAR Surgical (STAA) has been analyzed by 7 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 0% recommend Buy, 86% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Hold based on their latest research and market trends.

According to 7 analysts, STAAR Surgical (STAA) has a Hold consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.